Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma

Journal of Cell Biology

Volumn 167, Issue 5, 2004, Pages 925-934

  Thomas, David M ^a   Johnson, Sandra A ^d   Sims, Natalie A ^d   Trivett, Melanie K ^a   Slavin, John L ^a   Rubin, Brian P ^f   Waring, Paul ^a   McArthur, Grant A ^a   Walkley, Carl R ^a   Holloway, Andrew J ^a   Diyagama, Dileepa ^a   Grim, Jonathon E ^e   Clurman, Bruce E ^e   Bowtell, David D L ^a   Lee, Jong Seo ^b   Gutierrez, Gabriel M ^b,g   Piscopo, Denise M ^b   Carty, Shannon A ^c   Hinds, Philip W ^b,g  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR RUNX2; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SUPPRESSOR GENE;

ANIMALS; BONE NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DNA-BINDING PROTEINS; FEEDBACK, BIOCHEMICAL; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NIH 3T3 CELLS; OSTEOBLASTS; OSTEOCALCIN; OSTEOSARCOMA; PHENOTYPE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 10344237022     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200409187     Document Type: Article

References (59)

1. KIP1) in retinoblastoma protein-mediated senescence. Mol. Cell Biol. 21:3616-3631.
2. Aubin, J.E. 1998. Bone stem cells. J. Cell. Biochem. Suppl. 30-31:73-82.
3. Balint, E., D. Lapointe, H. Drissi, C. Van Der Meijden, D.W. Young, A.J. Van Wijnen, J.L. Stein, G.S. Stein, and J.B. Lian. 2003. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J. Cell. Biochem. 89:401-426.
4. Baylin, S.B., and J.G. Herman. 2000. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:168-174.
5. Bodine, P.V., M. Trailsmith, and B.S. Komm. 1996. Development and characterization of a conditionally transformed adult human osteoblastic cell line. J. Bone Miner. Res. 11:806-819.
6. KIP1. Genes Dev. 11:2335-2346.
7. Chambers, T.J., J.A. Darby, and K. Fuller. 1985. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res. 241:671-675.
8. Dahlin, D.C. 1957. Bone Tumors. Charles C. Thomas, Springfield, IL. 224 pp.
9. de Nooij, J.C., M.A. Letendre, and I.K. Hariharan. 1996. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell. 87:1237-1247.
10. Dimri, G.P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley. E.E. Medrano, M. Linskens, I. Rubelj, and O. Pereira-Smith. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:9363-9367.
11. KIP1) contributes to growth and differentiation of osteoblasts. Cancer Res. 59:3705-3711.
12. Ducy, P., and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1858-1869.
13. Ducy, P., R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty. 1997. Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 89:747-754.
14. Ducy, P., M. Starbuck, M. Priemel, J. Shen, G. Pinero, V. Geoffroy, M. Amling, and G. Karsenty. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1025-1036.
15. KIP1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 8:431-440.
16. KIP1)-deficient mice. Cell. 85:733-744.
17. Fero, M.L., E. Randel, K.E. Gurley, J.M. Roberts, and C.J. Kemp. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature. 396:177-180.
18. Feuerbach, D., E. Loetscher, K. Buerki, T.K. Sampath, and J.H. Feyen. 1997. Establishment and characterization of conditionally immortalized stromal cell lines from a temperature-sensitive T-Ag transgenic mouse. J. Bone. Miner. Res. 12:179-190.
19. Fredersdorf, S., J. Burns, A.M. Milne, G. Packham, L. Fallis, C.E. Gillett, J.A. Royds, D. Peston, P.A. Hall, A.M. Hanby, et al. 1997. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA. 94:6380-6385.
20. Goldstein, S. 1990. Replicative senescence: the human fibroblast comes of age. Science. 249:1129-1133.
21. Gori, F., T. Thomas, K.C. Hicok, T.C. Spelsberg, and R.L. Riggs. 1999. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J. Bone Miner. Res. 14:1522-1535.
22. Grigoriadis, A.E., K. Schellander, Z.Q. Wang, and E.F. Wagner. 1993. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122:685-701.
23. Gronthos, S., A.C. Zannettino, S.J. Hay, S. Shi, S.E. Graves, A. Kortesidis, and P.J. Simmons. 2003. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci. 116:1827-1835.
24. Harada, H., S. Tagashira, M. Fujiwara, S. Ogawa, T. Katsumata, A. Yamaguchi, T. Komori, and M. Nakatsuka. 1999. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem. 274:6972-6978.
25. Hinds, P.W., S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:993-1006.
26. KIP1) during contact-induced growth arrest in vascular endothelial cells. Exp. Cell Res. 271:356-367.
27. Hopyan, S., N. Gokgoz, R.S. Bell, I.L. Andrulis, B.A. Alman, and J.S. Wunder. 1999. Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumors. J. Orthop. Res. 17:633-638.
28. Kawamata, N., R. Morosetti, C.W. Miller, D. Park, K.S. Spirin, T. Nakamaki, S. Takeuchi, Y. Hatta, J. Simpson, S. Wilcyznski, et al. 1995. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res. 55:2266-2269.
29. KIP1). Cell. 85:721-732.
30. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:755-764.
31. Lane, M.E., K. Sauer, K. Wallace, Y.N. Jan, C.F. Lehner, and H. Vaessin. 1996. Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell. 87:1225-1235.
32. Levanon, D., V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics. 23:425-432
33. Li, Q.L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X.Z. Chi, K.Y. Lee, S. Nomura, C.W. Lee, S.B. Ran, et al. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124.
34. Lund, A.H., and M. van Lohuizen. 2002. RUNX: a trilogy of cancer genes. Cancer Cell. 1:213-215.
35. Morgenstern, J.P., and H. Land. 1990. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 18:1068.
36. Mundlos, S., F. Otto, C. Mundlos, J.B. Mulliken. A.S. Aylsworth, S. Albright, D. Lindhout, W.G. Cole, W. Henn, J.H. Knoll, et al. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:773-779.
37. KIP1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
38. Ogasawara, T., H. Kawaguchi, S. Jinno, K. Hoshi, K. Itaka, T. Takato, K. Nakamura, and H. Okayama. 2004. Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6. Mol. Cell. Biol. 24:6560-6568.
39. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA. 90:6859-6863.
40. Okahashi, N., Y. Murase, T. Koseki, T. Sato, K. Yamato, and T. Nishihara. 2001. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1). J. Cell. Biochem. 80:339-345.
41. Otto, F., A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, I.R. Rosewell, G.W. Stamp, R.S. Beddington, S. Mundlos, B.R. Olsen, et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:765-771.
42. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
43. Perry, C., A. Eldor, and H. Soreq. 2002. Runx1/AML1 in leukemia: disrupted association with diverse protein partners. Leuk. Res. 26:221-228.
44. Philipp-Staheli, J., K.H. Kim, D. Liggitt, K.E. Gurley, G. Longton, and C.J. Kemp. 2004. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development. Oncogene. 23:905-913.
45. Pollack, J.R. 2002. RNA common reference sets. In DNA Microarrays: A Molecular Cloning Manual. D.D.L. Bowtell and J. Sambrook, editors. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 168-177
46. Ponce-Castaneda, M.V., M.H. Lee, E. Latres, K. Polyak, L. Lacombe, K. Montgomery, S. Mathew, K. Krauter, J. Sheinfeld, J. Massague, et al. 1995. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res. 55:1211-1214.
47. Pratap, J., M. Galindo, S.K. Zaidi, D. Vradii, B.M. Bhat, J.A. Robinson, J.Y. Choi, T. Komori, J.L. Stein, J.B. Lian, et al. 2003. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res. 63:5357-5362.
48. Sellers, W.R., B.C. Novitch, S. Miyake, A. Heith, G.A. Otterson, F.J. Kaye, A.B. Lassar, and W.G. Kaelin Jr. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12:95-106.
49. Serrano, M., A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
50. Sherr, C.J., and J.M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
51. Sims, N.A., P. Clement-Lacroix, F. Da Ponte, Y. Bouali, N. Binart, R. Moriggl, V. Coffin, K. Coschigano, M. Gaillard-Kelly, J. Kopchick, et al. 2000. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J. Clin. Invest. 106:1095-1103.
52. Slingerland, J., and M. Pagano. 2000. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell. Physiol. 183:10-17.
53. Stein, G.S., J.B. Lian, J.L. Stein, A.J. van Wijnen, and M. Monetcino. 1996. Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76:593-629.
54. Sunters, A., D.P. Thomas, W.A. Yeudall, and A.E. Grigoriadis. 2004. Accelerated cell cycle progression in osteoblasts overexpressing the c-fos protooncogene: induction of cyclin A and enhanced CDK2 activity. J. Biol. Chem. 279:9882-9891.
55. Thirunavukkarasu, K., M. Mahajan, K.W. McLarren, S. Stifani, and G. Karsenty. 1998. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol. Cell. Biol. 18:4197-4208.
56. Thomas, D.M., S.A. Carty, D.M. Piscopo, J.S. Lee, W.F. Wang, W.C. Forrester, and P.W. Hinds. 2001. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell. 8:303-316.
57. Toguchida, J., K. Ishizaki, M.S. Sasaki, Y. Nakamura, M. Ikenaga, M. Kato, M. Sugimot, Y. Kotoura, and T. Yamamuro. 1989. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature. 338:156-158.
58. Tsuji, K., Y. Ito, and M. Noda. 1998. Expression of the PEBP2αA/AML3/ CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells. Bone. 22:87-92.
59. Yang, Y.H., S. Dudoit, P. Luu, D.M. Lin, V. Peng, J. Ngai, and T.P. Speed. 2002. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30:e15.